用户18509225712018-09-25 14:47
$DelMar制药(DMPI)$ 计划于北京时间 2018-09-26 04:30(2018/09/25 16:30 EDT)举行 2018 财年 Q4 财报电话会议。查看全文
Just-a-Novice2018-02-16 13:49
$DelMar制药(DMPI)$ There's one thing I'm not certain about:After fast track designation making a phase 2 trial pivatol, does sponsor still have visibility on progress of the trial?Guess should ask expert in biotech area~ @淘沙见金查看全文
Just-a-Novice2018-02-16 00:31
$DelMar制药(DMPI)$
Speculative exciting news under the surface of seemingly bad news.
The $3 mln quaterly spending wasn't that bad, what seemed to be bad was the co put the phase 3 trial on hold.
But, everyone knows to not put all eggs into one basket. The on...查看全文
$DelMar制药(DMPI)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-20-022614 Size: 16 KB 网页链接
$DelMar制药(DMPI)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001213900-20-022409 Act: 34 Size: 45 KB 网页链接
$DelMar制药(DMPI)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-20-022410 Size: 46 KB 网页链接
$DelMar制药(DMPI)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-20-018865 Size: 11 KB 网页链接
$DelMar制药(DMPI)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-001631 Act: 33 Size: 1 KB 网页链接
$DelMar制药(DMPI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-20-016559 Size: 9 KB 网页链接
$DelMar制药(DMPI)$ S-4/A [Amend] Registration of securities, business combinations Accession Number: 0001193125-20-185478 Act: 33 Size: 12 MB 网页链接
$DelMar制药(DMPI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-016315 Size: 8 KB 网页链接